The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) yesterday issued a negative opinion on Gentium SpA's marketing application for defibrotide (Defitelio) for ...
Role of consolidation therapy in adults with high-risk acute myeloid leukemia aged ≤ 60 years: Results of a prospective multicenter trial Conclusions: 1) ADR reporting is more complete in the clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback